Nucleic Acid Specialization TATAA Biocenter specializes in high sensitivity nucleic acid analyses for regulated and nonregulated bioanalysis, offering assay development, validation, and high throughput workflows to accelerate time to market. Target biopharma firms advancing nucleic acid therapies such as gene therapy and mRNA that need GLP and GCLP compliant CRO services and robust assay validation.

Compliance Advantage The lab is GLP accredited, GCLP compliant, and ISO/IEC 17025 certified with a purpose built facility designed to minimize contamination and ensure data integrity. Position as a trusted partner for regulatory ready data packages, audits, and manufacturing quality assessments.

Integrated Partnerships TATAA already collaborates with sequencing and analytics providers such as Universal Sequencing Technology, Olink, and Byteblocks and offers end to end capabilities from data generation to analysis. This enables bundled services for multiomics or long read sequencing programs and scalable CRO collaborations.

Growth Momentum Recent leadership appointments in marketing and bioinformatics indicate a ramp up in client outreach and expanded computational biology capabilities. Leverage these developments for coordinated campaigns around bioinformatics services and European market expansion.

European Footprint Based in Gothenburg with an EU footprint and revenue in the tens of millions, TATAA presents opportunities to target European biotech and pharma firms seeking regional, high quality nucleic acid analytics, biomarker development, and manufacturing QC services.